Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

7/10/2018 Database Update: Pharmaceutical Drug Export from Russia (March 2018)

Between January and March 2018, Russia exported 5.05 bln RUB worth of ready-made drugs (custom clearance prices), the EEU countries excluded. In monetary terms, this is 1.2% higher than that of the same period of 2017. In physical terms, the dynamics are -3.7%, with 0.12 bln units. When calculated in minimum dosage units (MDU), the dynamics are -9%.

6/29/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (May 2018)

Between January and May 2018, Russia produced 132.2 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 2.3% lower than that of the same period of 2017, despite the relatively high May performance. In physical terms, Russia produced only 1.63 bln units over the period, which is 12% lower than that of the same period of 2017.

6/26/2018 Database Update: API Import to Russia (April 2018)

Between January and April 2018, Russia imported 30.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 31% higher than that of the same period of 2017. In physical terms, Russia imported 3,440 tons of APIs, which is 3.6% higher than that of the same period of 2017.

6/26/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (April 2018)

Between January and April 2018, Russia imported 19.3 bln RUB worth of veterinary products (free circulation prices). The import of feed supplements amounted to 10.6 bln RUB, with a 14% increase in monetary terms. The import of veterinary drugs follows with 8 bln RUB and a 16% increase, while the import of veterinary APIs amounted to 0.62 bln RUB and a 13% increase.

6/22/2018 Database Update: Pharmaceutical Drug Import to Russia (April 2018)

Between January and April 2018, Russia imported 156.1 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 0.9% higher than that of the same period of 2017, and 35.9 bln RUB worth of in-bulk drugs, which is 27% higher than those of the same period of 2017. In total, the dynamics in monetary terms are 0.5%.

All news [99]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.